IRIDEX Corporation
Medical Devices & Tech
1212 Terra Bella Avenue
Mountain View, CA 94043 USA
phone: (650) 940-4700
fax: (650) 940-4710
Symbol IRIX
Exchange Nasdaq
Founded 1989
Employees 114
www.iridex.com
Research Sector Medical Devices & Tech
Summary Description
Laser systems to treat eye diseases, including age-related macular degeneration and dermatological conditions
Management
Barry G. Caldwell, President and CEO; Eduardo Arias, Senior Vice President, International Sales and Business Development; James L. Donovan, Vice President, Corporate Business Development; Larry Tannenbaum, Chief Business Officer and Sr. Vice President; Timothy Powers, Vice President, Operations; Donald J. Todd, Vice President of Marketing; Meryl Rains, Vice President and Chief Financial Officer
Ownership
Financials Mkt Cap :35


* numbers in thousands

 
Keywords
laser, ophthalmology, dermatology, blindness, Diabetes, blood sugar, diabetic, metabolic, insulin, j2008

Comment | Printable Version | Sept. 01, 2008
If you work for IRIDEX Corporation and want to update this profile, click here

Description
IRIDEX develops, manufactures and markets semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin conditions in dermatology.
Products / Services
Lasers to treat vascular lesions, benign pigmented lesions, cutaneous lesions and acne vulgaris and green and infrared lasers with a wide range of compatible delivery devices including single use disposable probes to treat eye diseases.
Technology / Differentiation
Laser system includes a console, which generates the laser energy and a number of interchangeable peripheral delivery devices, including disposable delivery devices for use in specific clinical applications.
Market / Customers
The company's products are sold in the United States predominantly through a direct sales force and internationally through 68 independent distributors into 107 countries.
Competitors / Substitutes / Alternatives
Lumenis Ltd., Carl Zeiss Meditec AG, Alcon Inc., Quantel, Laserex, Nidek, Inc, Novartis, Eyetech, Palomar Technologies, Laserscope, Candela Corporation, Cutera Inc.
Strategy
The company utilizes a systems approach to product design. Each system includes a console that generates the laser energy and a number of interchangeable peripheral delivery devices, including disposable delivery devices, sometimes referred to as EndoProbes, for use in specific clinical applications. This approach allows customers to purchase a basic console system and add additional delivery devices as their needs expand or as new applications are developed.


2008-09-07-1480